JPMORGAN CHASE & CO - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,861,835
+2535.4%
608,490
+2769.6%
0.00%
Q2 2023$184,484
+197.6%
21,205
+1.6%
0.00%
Q1 2023$62,000
+112627.3%
20,868
+33.3%
0.00%
Q4 2022$55
-100.0%
15,651
-5.0%
0.00%
Q3 2022$131,000
+7.4%
16,480
+6.7%
0.00%
Q2 2022$122,000
-36.1%
15,447
-1.8%
0.00%
Q1 2022$191,000
+40.4%
15,730
+41.1%
0.00%
Q4 2021$136,000
+58.1%
11,152
+36.6%
0.00%
Q3 2021$86,000
-69.4%
8,164
-73.8%
0.00%
Q2 2021$281,000
+28000.0%
31,218
+25915.0%
0.00%
Q1 2021$1,000120
+500.0%
0.00%
Q4 2020$0200.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,190,921$50,920,00012.31%
ACUTA CAPITAL PARTNERS, LLC 307,944$3,742,0001.75%
Samsara BioCapital, LLC 480,000$5,832,0001.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,909,407$35,349,0001.08%
SILVERARC CAPITAL MANAGEMENT, LLC 185,666$2,256,0000.93%
Altium Capital Management LP 224,541$2,728,0000.91%
RA Capital Management 3,370,506$40,952,0000.89%
ESSEX INVESTMENT MANAGEMENT CO LLC 276,591$3,361,0000.42%
MYDA Advisors LLC 55,000$668,0000.26%
Atom Investors LP 40,855$496,0000.23%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders